ArticleNaunyn-Schmiedeberg's archives of pharmacology1995
Characterization of the sensitivity of cardiac outwardly-rectifying K+ channels to class III antiarrhythmics: the influence of inhibitory sulfonamide derivatives.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Elementary K+ currents through cardiac 66 pS outwardly-rectifying K+ channels isolated from cultured neonatal rat cardiocytes were recorded in the inside-out patch configuration. By analyzing the influence of inhibitory sulfonamide derivatives, the block phenomenology evoked by these class III antiarrhythmic drugs was studied. After isolation from their cellular environment, K+(outw.-rect.) channels became usually upregulated so that open probability increased with time to reach, within 3 min or longer, a several-fold enhanced steady state level. Nevertheless, the novel sulfonamide derivative HE93 (10-100 mumol/l) depressed NPo significantly within some hundred milliseconds on cytosolic administration with a calculated IC50 value of 38 mumol/l. Drug-induced channel blockade mainly emerged from an increased life time of the prolonged C2-state; tau closed (2) rose (at 100 mumol/l) to 269 +/- 20%. A C1-C2 reaction scheme can adequately describe closed time kinetics in the presence of HE93 but the occurrence of a specific, drug-evoked ultralong (< or = 60 ms) C-state and mainly underlying the NPo depression cannot be excluded. Sotalol (100 mumol/l) caused the same block phenomenology although a 2.6-fold larger IC50 value (half maximal inhibitory concentration) suggests a smaller potency to depress channel activity. Despite a close structural relationship with the both compounds HE93 and sotalol, glibenclamide (100 mumol/l) exerted no significant inhibitory influence (IC50 = 530 mumol/l) on K+ channel activity. Instead, this sulfonylurea interfered with open K+ channels with an association rate constant of 8.2 +/- 3.8 x 10(6) mol-1 s-1 to shorten their 0-state, as a sign of open channel blockade.(ABSTRACT TRUNCATED AT 250 WORDS)
Indexed as
Identifiers
8584048What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.